New Leaf Ventures Iii, L.p. - Net Worth and Insider Trading
New Leaf Ventures Iii, L.p. Net Worth
The estimated net worth of New Leaf Ventures Iii, L.p. is at least $5 Million dollars as of 2024-09-20. New Leaf Ventures Iii, L.p. is the 10% Owner of Harpoon Therapeutics Inc and owns about 224,284 shares of Harpoon Therapeutics Inc (HARP) stock worth over $5 Million. Details can be seen in New Leaf Ventures Iii, L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that New Leaf Ventures Iii, L.p. has not made any transactions after 2021-01-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of New Leaf Ventures Iii, L.p.
New Leaf Ventures Iii, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, New Leaf Ventures Iii, L.p. owns 6 companies in total, including Deciphera Pharmaceuticals Inc (DCPH) , Harpoon Therapeutics Inc (HARP) , and Arvinas Inc (ARVN) among others .
Click here to see the complete history of New Leaf Ventures Iii, L.p.’s form 4 insider trades.
Insider Ownership Summary of New Leaf Ventures Iii, L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| DCPH | Deciphera Pharmaceuticals Inc | 2017-09-27 | 10 percent owner |
| HARP | Harpoon Therapeutics Inc | 2021-01-11 | 10 percent owner |
| ARVN | Arvinas Inc | 2018-09-26 | 10 percent owner |
 | | 2018-06-20 | 10 percent owner |
| | 2018-05-24 | 10 percent owner |
| | 2016-06-21 | director |
New Leaf Ventures Iii, L.p. Latest Holdings Summary
New Leaf Ventures Iii, L.p. currently owns a total of 1 stock. New Leaf Ventures Iii, L.p. owns 224,284 shares of Harpoon Therapeutics Inc (HARP) as of January 11, 2021, with a value of $5 Million.
Latest Holdings of New Leaf Ventures Iii, L.p.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HARP | Harpoon Therapeutics Inc | 2021-01-11 | 224,284 | 23.01 | 5,160,775 |
Holding Weightings of New Leaf Ventures Iii, L.p.
New Leaf Ventures Iii, L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, New Leaf Ventures Iii, L.p. has made a total of 1 transactions in Harpoon Therapeutics Inc (HARP) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Harpoon Therapeutics Inc is the acquisition of 23,529 shares on January 11, 2021, which cost New Leaf Ventures Iii, L.p. around $4 Million.
Insider Trading History of New Leaf Ventures Iii, L.p.
- 1
New Leaf Ventures Iii, L.p. Trading Performance
GuruFocus tracks the stock performance after each of New Leaf Ventures Iii, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by New Leaf Ventures Iii, L.p. is -11.12%. GuruFocus also compares New Leaf Ventures Iii, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by New Leaf Ventures Iii, L.p. within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how New Leaf Ventures Iii, L.p.'s insider trading performs compared to the benchmark.
Performance of New Leaf Ventures Iii, L.p.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -10.57 | | | | | |
| Relative Return to S&P 500(%) | -12.96 | | | | | |
New Leaf Ventures Iii, L.p. Ownership Network
New Leaf Ventures Iii, L.p. Owned Company Details
What does Deciphera Pharmaceuticals Inc do?
Who are the key executives at Deciphera Pharmaceuticals Inc?
New Leaf Ventures Iii, L.p. is the 10 percent owner of Deciphera Pharmaceuticals Inc. Other key executives at Deciphera Pharmaceuticals Inc include EVP & Chief Medical Officer Matthew L Sherman , Chief Financial Officer Thomas Patrick Kelly , and Chief Commercial Officer Daniel C. Martin .
Deciphera Pharmaceuticals Inc (DCPH) Insider Trades Summary
Over the past 18 months, New Leaf Ventures Iii, L.p. made no insider transaction in Deciphera Pharmaceuticals Inc (DCPH). Other recent insider transactions involving Deciphera Pharmaceuticals Inc (DCPH) include a net sale of 23,797 shares made by Daniel C. Martin , a net sale of 12,184 shares made by Matthew L Sherman , and a net sale of 9,198 shares made by Thomas Patrick Kelly .
In summary, during the past 3 months, insiders sold 0 shares of Deciphera Pharmaceuticals Inc (DCPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 112,502 shares of Deciphera Pharmaceuticals Inc (DCPH) were sold and 21,000 shares were bought by its insiders, resulting in a net sale of 91,502 shares.
Deciphera Pharmaceuticals Inc (DCPH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Deciphera Pharmaceuticals Inc Insider Transactions
New Leaf Ventures Iii, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for New Leaf Ventures Iii, L.p.. You might contact New Leaf Ventures Iii, L.p. via mailing address: C/o New Leaf Venture Partners, 7 Times Square, Suite 3502, New York Ny 10036.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
